Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the languages menu
  5. Go to the help menu
  6. Go to the modules
  7. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. Canadian Web Sites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  
 
 

Media Room

Contact us

Sanofi Canada

2905 Place Louis-R.-Renaud
Laval, Quebec, H7V 0A3

Media inquiries

514-856-3860
Toll-free: 1-877-904-2667

Catherine Cunningham

Manager, Corporate and
Brand Communications
514-956-6120

General inquiries

514-956-6200
1-800-363-6364

Press Releases

Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012

20112010200920082007

Oct 17, 2018

Sanofi Canada is on a mission to raise awareness and money to help people living with diabetes, one of the leading causes of death and disability in Canada.1 In honor of Diabetes Awareness Month,...

More
Oct 1, 2018

Influenza has a significant human and economic impact due to the burden of illness and high number of hospitalizations. With the majority of these in seniors,i the impact on them and their...

More
Sep 27, 2018

Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) * Toujeo® receives provincial formulary coverage in Ontario * Lantus® gains improved provincial formulary coverage in Manitoba LAVAL, QC, Sept. 27,...

More
Sep 25, 2018
Studies show that Lovenox® (enoxaparin sodium) is an alternative to conventional heparin in preventing clotting during hemodialysis

Laval, Quebec – September 25, 2018 – Sanofi Canada announced today Health Canada’s approval of a new indication for Lovenox® (enoxaparin sodium) for the prevention of thrombus formation in...

More
Jul 10, 2018

Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) * CADTH recommendation for Dupixent™ disregards patient input and ignores clinical value LAVAL, QC, July 10, 2018 /CNW Telbec/ - Sanofi Genzyme is...

More
Jul 3, 2018

July 3, 2018, Toronto, ON – The Canadian Association of Radiation Oncology (CARO) and Sanofi Canada are pleased to announce three CARO members have been awarded the Sanofi-CARO Awards! $20,000...

More
Jun 27, 2018

Toujeo® (insulin glargine injection 300 Units/mL) met primary endpoint in lowering blood sugar levels and was non-inferior to insulin degludec in adults with type 2 diabetes not previously on...

More
Jun 22, 2018

For Canadian media only Laval, Quebec - Sanofi Canada is proud to support the health and well-being of Canadians. In collaboration with Health Canada, we are bringing life-saving treatment to help...

More
Jun 13, 2018

Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Three-quarters of employers are worried about the impact of unmanaged chronic disease Two-thirds (66%) of Canadian employees would consent to receive...

More
Jun 8, 2018

Sajeev Kohli, a Grade 11 student from Waterloo, Ontario, receives top honours in the Global Healthcare Challenge LAVAL, QC, June 7, 2018 /CNW Telbec/ - Sajeev Kohli, a grade 11 student science...

More
 

Corporate information

CORPORATE INFORMATION